Generate a tailored SOP for Dr. David Kerr. Improve your application with a focused, well-structured draft.
David Kerr is a Professor of Cancer Medicine at the Radcliffe Department of Medicine at the University of Oxford. He has made significant contributions to the field of colorectal clinical pathology, particularly through his role in various international adjuvant trials for chemotherapy in colorectal cancer. He has a deep interest in genetics and genomics, having established a biorepository of tissue and constitutional DNA (n=3500) which facilitates collaboration for the generation of cancer susceptibility Single Nucleotide Polymorphisms (SNPs). His research includes the characterization of prognostic mRNA signatures to assist in patient selection for chemotherapy and the development of biomarkers for the anti-angiogenic agent, bevacizumab. Throughout his career, he has collaborated with numerous researchers and has been a consultant physician in oncology.
Department of Politics and International Relations - Higher Level English requirement.